Project Grant H8I48985
- Federal Cooperative Agreement Summary Pennsylvania State University, operating as Penn State Milton S. Hershey Medical Center, received a $682,392 Cooperative Agreement award effective August 30, 2025, through August 29, 2030, from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The Pennsylvania Colorectal Cancer Alliance to Reduce...
- Summary The Alabama Department of Public Health received a $483,280 Cooperative Agreement award dated August 30, 2025, through the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The Alabama Colorectal Cancer Program (ACRCP) will implement evidence-based interventions to increase colorectal cancer screening rates among at-risk Alabama...
- Federal Cooperative Agreement Summary Health Research, Inc., through its Center for Community Health division, received a $684,000 cooperative agreement awarded August 30, 2025, by the National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The five-year award, extending through August 29, 2030, funds the New York State Department of Health to increase colorectal cancer screening rates...
- Health Quality Partners of Southern California (HQP) received a $1,215,984 Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800) effective August 30, 2025, through August 29, 2030. HQP will implement a multi-component, systems-based initiative to increase colorectal cancer screening rates among adults aged...
- Summary of PROTECT-AR Cooperative Agreement Award The University of Arkansas for Medical Sciences (UAMS) Primary Care Population Health Service Line received a $1,633,260 cooperative agreement from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion, effective August 30, 2025 through August 29, 2030, under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The PROTECT-AR initiative implements...
- This $500,000 Project Grant award from the Health Resources and Services Administration (HRSA) under the Health Center Program (CFDA 93.224) will support Neighborhood Health, a non-profit community health center in Northern Virginia, in increasing breast and colorectal cancer screening rates among its largely low-income, immigrant, and uninsured patient population. The two-year project aims to remove barriers to accessing and completing cancer screenings by implementing state-of-the-art...
- The Health Resources and Services Administration (HRSA) awarded a $499,973 Project Grant under the Health Center Program (CFDA 93.224) to Midtown Community Health Center, Inc. (MCHC) to accelerate colorectal cancer screening among underserved patients in Utah. MCHC is partnering with eight other HRSA health centers, the Huntsman Cancer Institute, and the Association for Utah Community Health to improve screening rates, referral to care, and treatment for patients aged 50-75. The project aims...
- The Commonwealth of Virginia-State Board of Health, operating through the Richmond City Health District, received a $683,891 cooperative agreement from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The award was made on August 30, 2025, with a five-year performance period through August 29, 2030. The project addresses documented...
- Federal Grant Award Summary The National Cancer Institute awarded Fred Hutchinson Cancer Center a $621,406 Project Grant under the 21st Century Cures Act – Beau Biden Cancer Moonshot program (CFDA 93.353) on August 1, 2025, for the PROACT study: Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel Interventions. The project, which extends through July 31, 2030, will evaluate a multilevel intervention designed to improve follow-up colonoscopy completion rates among...
- Federal Cooperative Agreement Award Summary The Ohio Association of Community Health Centers (OACHC) received a $510,000 Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800), effective August 30, 2025 through August 29, 2030. OACHC will implement a statewide colorectal cancer (CRC) screening initiative across...
ACCELERATING CANCER SCREENING - PRIMARY HEALTH NETWORK (PHN) IS PROPOSING TO ADDRESS SCREENING RATES AND REFERRAL TO CARE AND TREATMENT FOR COLORECTAL CANCER IN THREE (3) COUNTIES WITHIN ITS SERVICE AREA IN PENNSYLVANIA: BEAVER COUNTY; ERIE COUNTY; AND LAWRENCE COUNTY. THIS WILL BE ACCOMPLISHED VIA PARTNERSHIP WITH UPMC HILLMAN CANCER CENTER, AN NCI-DESIGNATED CANCER CENTER (DESCRIBED IN MORE DETAIL BELOW). THIS PROJECT WILL TARGET PATIENTS AT FIVE (5) PHN LOCATIONS WITHIN THE TARGETED COUNTIES. THESE INCLUDE: AUTUMN STREET HEALTH CENTER IN BEAVER COUNTY (99 AUTUMN STREET, ALIQUIPPA, PA 15001); BEAVER FALLS PRIMARY CARE IN BEAVER COUNTY (1302 SEVENTH AVENUE, BEAVER FALLS, PA 15010); WAYNE PRIMARY CARE IN ERIE COUNTY (650 EAST AVENUE, ERIE, PA 16503); ELLWOOD CITY HEALTH CENTER IN LAWRENCE COUNTY (304 EVANS DRIVE, SUITE 201, ELLWOOD CITY, PA 16117); AND NEW CASTLE PRIMARY CARE IN LAWRENCE COUNTY (1112 SOUTH MILL STREET, NEW CASTLE, PA 16101). EACH OF THESE AREAS WAS CHOSEN DUE TO LOWER SCREENING RATES FOR COLORECTAL CANCER (DESCRIBED IN THE NEED SECTION AND OTHER PORTIONS OF THIS NARRATIVE), AS WELL AS OVERALL AREA NEED AND PRESENCE OF MINORITY/UNDERSERVED POPULATIONS (SUCH AS THE REFUGEE POPULATION IN ERIE COUNTY). THESE SPECIFIC NEEDS AND LOWER SCREENING RATES ARE FULLY DESCRIBED IN THE NEED SECTION AND OTHER PORTIONS OF THIS NARRATIVE. PHN'S CURRENT COLORECTAL SCREENING RATE FOR THE THREE-COUNTY SERVICE AREA IS 35% (REPRESENTING APPROXIMATELY 250 PATIENTS VIA 2021 UDS DATA). PHN IS PROJECTING TO INCREASE THE NUMBER OF PATIENTS RECEIVING A COLORECTAL CANCER SCREENING BY APPROXIMATELY 50% (OR AN ADDITIONAL 125 PATIENTS) BY THE END OF THE 2-YEAR PROJECT PERIOD, RESULTING IN AN OVERALL SCREENING RATE OF APPROXIMATELY 39%. PHN WILL ALSO ESTABLISH A BASELINE FOR PATIENTS REFERRED TO TREATMENT WITHIN 30 DAYS OF RECEIVING AN ABNORMAL SCREENING RESULT (NOT CURRENTLY TRACKED). ONCE THE BASELINE IS ESTABLISHED, PHN PROJECTS INCREASING IT BY A MINIMUM OF 10% (I.E., IF THE BASEL INE IS 100 PATIENTS TRANSITIONED TO TREATMENT WITHIN 30 DAYS, PHN PROPOSES INCREASING THAT BY 10 PATIENTS), OVER THE COURSE OF THE PROJECT PERIOD.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 12/3/25 | ||
| Not listed | $0 | 3/14/25 | ||
| Not listed | $0 | 3/14/25 | ||
| Not listed | $0 | 3/21/24 | ||
| Not listed | $0 | 3/21/24 |